These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23496662)

  • 41. [Vaccines against substance abuse].
    Mørland J
    Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2974-6. PubMed ID: 17117198
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunotherapy for drug abuse.
    Shen X; Kosten TR
    CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):876-9. PubMed ID: 22229313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Harnessing myeloid dendritic cell subsets in novel cancer immunotherapy].
    Ueno H; Fay J; Palucka AK; Banchereau J
    Rinsho Ketsueki; 2011 Jul; 52(7):505-13. PubMed ID: 21821982
    [No Abstract]   [Full Text] [Related]  

  • 44. Cancer vaccines: pessimism in check.
    Mocellin S; Mandruzzato S; Bronte V; Marincola FM
    Nat Med; 2004 Dec; 10(12):1278-9; author reply 1279-80. PubMed ID: 15580242
    [No Abstract]   [Full Text] [Related]  

  • 45. Human Vaccines & Immunotherapeutics: News.
    Hum Vaccin Immunother; 2017 Sep; 13(9):1958-1959. PubMed ID: 28937944
    [No Abstract]   [Full Text] [Related]  

  • 46. Personalized cancer vaccines.
    Jain KK
    Expert Opin Biol Ther; 2010 Dec; 10(12):1637-47. PubMed ID: 20979567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current Opinion in Immunology. Vaccines. Introduction.
    Ertl HC; Lanzavecchia A
    Curr Opin Immunol; 2010 Jun; 22(3):355-7. PubMed ID: 20510596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer vaccines: the state of the art.
    Finn OO; Banchereau J
    Semin Immunol; 2010 Jun; 22(3):103-4. PubMed ID: 20552730
    [No Abstract]   [Full Text] [Related]  

  • 49. [Allergen immunotherapy--therapeutic vaccines for allergy and asthma].
    Pneumologie; 1999 Dec; 53(12 Suppl):1-4. PubMed ID: 10686786
    [No Abstract]   [Full Text] [Related]  

  • 50. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New strategies in cancer immunotherapy].
    Ruan RS; Xu KC
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):943-6. PubMed ID: 22340107
    [No Abstract]   [Full Text] [Related]  

  • 52. The problem with potency.
    Scott CT
    Nat Biotechnol; 2005 Sep; 23(9):1037-9. PubMed ID: 16151384
    [No Abstract]   [Full Text] [Related]  

  • 53. The science and medicine of human immunology.
    Pulendran B; Davis MM
    Science; 2020 Sep; 369(6511):. PubMed ID: 32973003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer vaccines and immunotherapies: emerging perspectives.
    Henderson RA; Mossman S; Nairn N; Cheever MA
    Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [New era of tumor immunotherapy].
    Yoshitake Y; Nakatsura T; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():46-55. PubMed ID: 15861634
    [No Abstract]   [Full Text] [Related]  

  • 56. New and emerging vaccination strategies for prevention and treatment of dermatological diseases.
    Walden P; Sterry W
    Expert Rev Vaccines; 2004 Aug; 3(4):421-31. PubMed ID: 15270647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer immunotherapy with autologous and allogeneic vaccines: a practical overview.
    Shinitzky M; Skornick Y
    Prog Clin Biol Res; 1990; 348():95-125. PubMed ID: 2201036
    [No Abstract]   [Full Text] [Related]  

  • 58. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Animal Models and the Development of Vaccines to Treat Substance Use Disorders.
    Ohia-Nwoko O; Kosten TA; Haile CN
    Int Rev Neurobiol; 2016; 126():263-91. PubMed ID: 27055616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy?
    Lemos H; Huang L; McGaha T; Mellor AL
    Expert Rev Clin Immunol; 2015 Jan; 11(1):155-65. PubMed ID: 25521938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.